It's a non-randomized, intervention, prospective, single-center study. The aim of the work is to identify of biomarkers of unstable atherosclerosis in brachiocephalic arteries Tasks: * identify microRNAs, the expression of which is characteristic of unstable atherosclerotic lesions; * to assess the relationship of miRNA and trimethylamine N-oxide with the progression of unstable atherosclerotic lesions; * to determine the effect of the level of plasma trimethylamine N-oxide on the progression of atherosclerotic lesions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
blood microRNA
Timeframe: at study entry, before carotid endarterectomy.
plaque microRNA
Timeframe: immediately after carotid endarterectomy
blood TMAO
Timeframe: at study entry, before carotid endarterectomy
histological examination of atherosclerotic plaque
Timeframe: immediately after carotid endarterectomy
intima microRNA
Timeframe: immediately after carotid endarterectomy